Shunt device and method for treating ocular disorders

US9827143B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9827143-B2
Application numberUS-201615349885-A
CountryUS
Kind codeB2
Filing dateNov 11, 2016
Priority dateApr 26, 1999
Publication dateNov 28, 2017
Grant dateNov 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.

First claim

Opening claim text (preview).

What is claimed is: 1. An ocular implant configured to maintain patency of Schlemm's canal in a stenting fashion, the ocular implant comprising: a body of biocompatible material of a size and shape adapted to be at least partially circumferentially retained within a portion of Schlemm's canal, wherein the body is non-tubular, wherein the body is curved, and wherein the body comprises at least one opening along its length configured to facilitate passage of aqueous humor. 2. The ocular implant of claim 1 , wherein a portion of the body is oriented to be positioned in the anterior chamber after implantation. 3. The ocular implant of claim 1 , wherein the body is shaped to facilitate flow of aqueous humor from Schlemm's canal into one or more collecting channels. 4. The ocular implant of claim 1 , wherein the body is elongate and comprises multiple ovoid openings along its length. 5. An implant designed to relieve excessive intraocular pressure, the implant comprising: a flexible, elongate body of biocompatible material for implantation in a living human eye comprising a curved channel shaped to be at least partially positioned within a circumferential length of Schlemm's canal; wherein the channel is at least partially open along its length to facilitate flow of aqueous humor from Schlemm's canal into one or more collecting channels; the channel further having one or more portals oriented to allow flow of aqueous humor from an anterior chamber of the eye into Schlemm's canal. 6. The implant of claim 5 , wherein the channel has a trough-like shape to provide stenting support for the patency of Schlemm's canal. 7. The implant of claim 5 , wherein the channel includes multiple portals along its length. 8. The implant of claim 7 , wherein at least some of the portals are ovoid in shape. 9. The implant of claim 5 , wherein a distal portion of the elongate body comprises the curved channel, and wherein the elongate body further comprises a proximal portion that is oriented to be positioned at least partially in the anterior chamber after implantation. 10. The implant of claim 9 , wherein the proximal portion is at least partially open to receive aqueous humor from the anterior chamber, and wherein the proximal portion is in fluid communication with the distal portion to facilitate flow of aqueous humor into Schlemm's canal. 11. The implant of claim 5 , wherein the biocompatible material comprises metal. 12. The implant of claim 5 , wherein a distal end of the body is non-tubular. 13. The implant of claim 5 , wherein the opening along the length of the channel is oriented toward one or more of the collecting channels when located within Schlemm's canal. 14. The implant of claim 5 , wherein the opening along the length of the channel extends to a distal end of the body. 15. The implant of claim 5 , wherein the channel is open along a length that extends to a distal end of the body. 16. An implant designed to relieve excessive intraocular pressure, the implant comprising: a body of biocompatible material for implantation in a living human eye, wherein the body has a non-linear shape before insertion into the eye; the body comprising a channel shaped to be at least partially positioned within a circumferential length of Schlemm's canal; wherein the channel is at least partially open along its length and oriented to facilitate flow of aqueous humor from Schlemm's canal into one or more collecting channels. 17. The implant of claim 16 , wherein a distal portion of the body comprises the channel, and wherein the body further comprises a proximal portion that is oriented to be positioned at least partially in an anterior chamber of the eye after implantation. 18. The implant of claim 17 , wherein the proximal portion comprises an opening to receive aqueous humor from the anterior chamber, and wherein the proximal portion is in fluid communication with the distal portion to facilitate flow of aqueous humor into Schlemm's canal. 19. The implant of claim 18 , wherein the proximal portion is shorter in length than the distal portion. 20. The implant of claim 16 , wherein the biocompatible material comprises metal. 21. The implant of claim 16 , wherein a distal end of the body is non-tubular. 22. The implant of claim 16 , wherein the opening along the length of the channel extends to a distal end of the body. 23. The implant of claim 16 , wherein the channel is open along a length that extends to a distal end of the body. 24. An implant designed to relieve excessive intraocular pressure, the implant comprising: a biocompatible metal stent shaped to be partially circumferentially positioned within a length of Schlemm's canal in a living human eye; wherein the stent comprises a non-tubular open shape to provide stenting support for the patency of Schlemm's canal and to improve flow of aqueous humor into Schlemm's canal after implantation of the stent; wherein at least one cross-section of the stent approximates a partial circumference of a circle having an inner diameter between about 100 micrometers and 500 micrometers. 25. The implant of claim 24 , wherein a portion of the stent is oriented to be positioned in an anterior chamber of the eye after implantation. 26. The implant of claim 24 , wherein the stent has a non-linear shape before insertion into the eye. 27. The implant of claim 24 , wherein the stent is elongate and further includes multiple holes along its length. 28. The implant of claim 27 , wherein at least some of the holes are oval-shaped. 29. The implant of claim 24 , wherein the non-tubular open shape of the stent is disposed to facilitate flow of aqueous humor into one or more collecting channels in the eye. 30. The implant of claim 24 , wherein the at least one cross-section is approximately semi-circular. 31. The implant of claim 24 , wherein the stent is oriented so as to open toward one or more of the collecting channels when located within Schlemm's canal. 32. A surgical method for relieving excessive intraocular pressure by implanting a medical device in an eye, the method comprising: inserting a non-luminal open stent into a living human eye, wherein at least one cross-section of the stent approximates a partial circumference of a circle having an inner diameter between about 100 micrometers and 500 micrometers; creating an incision in a trabecular meshwork of the eye; positioning the stent through the incision so that the stent is partially located in an anterior chamber of the eye and partially located within a circumferential length of Schlemm's canal in the eye; leaving the stent in the eye as a permanent implant to permit increased flow of aqueous humor from the anterior chamber into Schlemm's canal. 33. The method of claim 32 , wherein the stent provides stenting support for the patency of Schlemm's canal. 34. The method of claim 32 , wherein the stent is oriented to open toward one or more collecting channels of the eye to facilitate flow of aqueous humor. 35. The method of claim 34 , wherein the portion of the stent positioned in Schlemm's canal further includes multiple openings along its length through which aqueous humor is permitted to flow from the anterior chamber into Schlemm's canal

Assignees

Inventors

Classifications

  • Means for introducing or releasing pharmaceutical products into the body · CPC title

  • Eyes · CPC title

  • implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

  • Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable · CPC title

  • Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9827143B2 cover?
Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-direction…
Who is the assignee on this patent?
Glaukos Corp
What technology area does this patent fall under?
Primary CPC classification A61F9/00781. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).